Esophageal Adenocarcinoma Clinical Trials in Baltimore, Maryland
5 recruitingBaltimore, Maryland
Showing 1–5 of 5 trials
Recruiting
Phase 1
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
Advanced Gastric CancerMetastatic Solid TumorsAdvanced Non-squamous Non-small-cell Lung Cancer+4 more
BeiGene514 enrolled17 locationsNCT06585488
Recruiting
Phase 3
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+12 more
Alliance for Clinical Trials in Oncology382 enrolled786 locationsNCT05677490
Recruiting
Phase 3
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+10 more
NRG Oncology300 enrolled95 locationsNCT03801876
Recruiting
Not Applicable
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Esophageal AdenocarcinomaBarrett EsophagusBarretts Esophagus With Dysplasia
University of Colorado, Denver680 enrolled23 locationsNCT05753748
Recruiting
Not Applicable
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
Esophageal AdenocarcinomaBarrett EsophagusGastroesophageal Reflux
Case Comprehensive Cancer Center800 enrolled5 locationsNCT06687603